Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: DRUG: Exemestane|DRUG: Everolimus
Sponsor: Organisation for Oncology and Translational Research